Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Peptone Ltd. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. Both of these actions are assigned to 1 distinct examiner, which is a lower count than the 2 pending office actions. These actions are also contained within 1 distinct art unit, matching the count of 1 distinct examiner.
The busiest examiner, PULLIAM, JOSEPH CONSTANTINE, is responsible for 2 busiest examiner pending actions. Because the total number of pending office actions is also 2, this examiner manages the total active workload for the company. The 2 pending office actions are subject to the review of this individual within the 1 distinct art unit. Practitioners should focus on the specific examination style of PULLIAM, JOSEPH CONSTANTINE, as his 2 busiest examiner pending actions represent the entirety of the portfolio's current Biotechnology & Pharmaceuticals prosecution. The 1 distinct art unit indicates a focused technical scope for both of the 2 pending office actions. This concentration under 1 distinct examiner means that the outcome of one action may be indicative of the outcome for the other.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| §101 + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PULLIAM, JOSEPH CONSTANTINE | 2 | 38.5% | +33.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18598701 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | — |
| 18513867 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18598701 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | — |
| 18513867 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | — |
| Art Unit | Apps |
|---|---|
| 1687 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18598701 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | 1687 | §101Other | Final Rejection | — | Pending | Mar 07, 2024 |
| 18513867 | SPACIO-TEMPORAL DETERMINATION OF POLYPEPTIDE STRUCTURE | PULLIAM, JOSEPH CONSTANTINE | 1687 | §101§103§112Other | Non-Final OA | — | Pending | Nov 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPeptone Ltd. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph Constantine Pulliam has the most, with 2 of Peptone Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
